Michael Kometer
Michael Kometer
Unknown affiliation
Verified email at bli.uzh.ch
Title
Cited by
Cited by
Year
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
FX Vollenweider, M Kometer
Nature Reviews Neuroscience 11 (9), 642, 2010
4702010
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
E Studerus, M Kometer, F Hasler, FX Vollenweider
Journal of psychopharmacology 25 (11), 1434-1452, 2011
2642011
Prediction of psilocybin response in healthy volunteers
E Studerus, A Gamma, M Kometer, FX Vollenweider
PloS one 7 (2), e30800, 2012
1692012
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations
M Kometer, A Schmidt, L Jäncke, FX Vollenweider
Journal of Neuroscience 33 (25), 10544-10551, 2013
1622013
Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors
M Kometer, A Schmidt, R Bachmann, E Studerus, E Seifritz, ...
Biological psychiatry 72 (11), 898-906, 2012
1382012
Modeling ketamine effects on synaptic plasticity during the mismatch negativity
A Schmidt, AO Diaconescu, M Kometer, KJ Friston, KE Stephan, ...
Cerebral cortex 23 (10), 2394-2406, 2013
972013
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers
BB Quednow, M Kometer, MA Geyer, FX Vollenweider
Neuropsychopharmacology 37 (3), 630-640, 2012
952012
Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments
A Schmidt, R Bachmann, M Kometer, PA Csomor, KE Stephan, E Seifritz, ...
Neuropsychopharmacology 37 (4), 865-875, 2012
812012
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
M Kometer, T Pokorny, E Seifritz, FX Volleinweider
Psychopharmacology 232 (19), 3663-3676, 2015
672015
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations
M Kometer, BR Cahn, D Andel, OL Carter, FX Vollenweider
Biological psychiatry 69 (5), 399-406, 2011
552011
Aberrant current source-density and lagged phase synchronization of neural oscillations as markers for emerging psychosis
A Ramyead, M Kometer, E Studerus, S Koranyi, S Ittig, U Gschwandtner, ...
Schizophrenia bulletin 41 (4), 919-929, 2015
522015
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
A Schmidt, M Kometer, R Bachmann, E Seifritz, F Vollenweider
Psychopharmacology 225 (1), 227-239, 2013
512013
Effect of psilocybin on empathy and moral decision-making
T Pokorny, KH Preller, M Kometer, I Dziobek, FX Vollenweider
International Journal of Neuropsychopharmacology 20 (9), 747-757, 2017
492017
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
L Smigielski, M Scheidegger, M Kometer, FX Vollenweider
NeuroImage 196, 207-215, 2019
412019
Prediction of psychosis using neural oscillations and machine learning in neuroleptic-naive at-risk patients
A Ramyead, E Studerus, M Kometer, M Uttinger, U Gschwandtner, P Fuhr, ...
The World Journal of Biological Psychiatry 17 (4), 285-295, 2016
322016
Serotonergic hallucinogen-induced visual perceptual alterations
M Kometer, FX Vollenweider
Behavioral Neurobiology of Psychedelic Drugs, 257-282, 2016
312016
Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin
F Bernasconi, A Schmidt, T Pokorny, M Kometer, E Seifritz, ...
Cerebral Cortex 24 (12), 3221-3231, 2014
282014
The electrophysiological effects of the serotonin 1A receptor agonist buspirone in emotional face processing
F Bernasconi, M Kometer, T Pokorny, E Seifritz, FX Vollenweider
European Neuropsychopharmacology 25 (4), 474-482, 2015
132015
Crowding deficits in the visual periphery of schizophrenia patients
R Kraehenmann, FX Vollenweider, E Seifritz, M Kometer
PLoS One 7 (9), e45884, 2012
132012
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
L Smigielski, M Kometer, M Scheidegger, R Krähenmann, T Huber, ...
Scientific reports 9 (1), 1-13, 2019
122019
The system can't perform the operation now. Try again later.
Articles 1–20